Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
FDAVoice blog: Life-saving, smart regulation on behalf of patients with aortic stenosis
By: Jeffrey Shuren, M.D., J.D.
At FDA’s medical devices center, we have a vision – it’s what we strive for each day in our review and assessment of new medical technology. And patients are at the very core of that vision: "Patients in the U.S. have access to high-quality, safe, and effective medical devices of public health importance first in the world."
TAVI: Edwards lands FDA approval for next-gen Sapien XT
Press Release: Edwards lifesciences launching Sapien XT valve in the U.S.
Abbott aims to expand Xience Prime patent for 1.7 years
Stentys closes $1.4M acquisition of Cappella’s Peel Away stent delivery device
Stentys said it’s closed the deal on the €1 million ($1.4 million) deal to acquire the Peel Away stent delivery system.
The cash-and-stock deal is the 1st strategic acquisition for Stentys, which makes a line of bare-metal and drug-eluting coronary stents.
FLASH: FDA approves Medtronic’s CoreValve for high-risk patients
Cardiovascular Systems launches COAST heart disease study
Medtronic confirms Corventis buy, expects to close this month
Appeals court upholds Gore win over St. Jude Medical
A federal appeals court today upheld a win for W.L. Gore & Assoc. in a patent war with St. Jude Medical (NYSE:STJ) over heart defect repair technology.
CardiAQ Valve accuses Neovasc of stealing trade secrets for Tiara valve
UPDATED June 6, 2014, with comment from Neovasc.